Clinical Trial

Vital Signs Collection Via "Comestai" App

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to verify and validate the parameters collected from mobile devices via the app named "Comestai" and from reference devices. The assessments considered to define comorbidities are included.. Specifically, collection of vital parameters (Blood Pressure, Heart Rate, Respiratory Rate, Oxygen Saturation) through the "Comestai" Application via mobile phones (using photoplethysmographic method) and reference devices such as Withings-Blood Pressure Monitor Connect® (for Blood Pressure), Polar Verity Sense® (for Heart Rate), Masimo-finger sensor® (for Oxygen Saturation, Respiratory Rate), comparing and confirming them. Consent will be sought for the viewing and collection of blood test results that are normally included in evaluations for subjects with overweight and/or obesity and/or diabetes. Estimated time required for each measurement recording: 10-15 minutes per subject Total number of subjects: 3000
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-19; most recent amendment 2025-11-18.
Status change: Not Yet Recruiting → Recruiting 2025-04-24
Trial Details
NCT Number NCT06427564
Lead Sponsor Buzzi Children's Hospital
Conditions Vital Signs
Enrollment 3,000 participants
Start Date 2024-06-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-21